The aim of this study was to analyze the associations of serum IGFBP-2 levels with COVID-19 severity, and therefore, serum IGFBP-2 levels were determined in healthy controls and patients with moderate and severe COVID-19 disease. Here, IGFBP2 is linked to COVID-19.